🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Assess the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy...
Status
Completed
Location
Piedmont Cancer Institute, P.C.
Start Date
2019-12-05
Trial ID
NCT04179396
Treatments Being Tested
This multicenter, international, Phase Ib/II trial consists of three stages...
Status
Completed
Location
HonorHealth Research Institute ? Bisgrove
Start Date
2012-01-11
Trial ID
NCT01485861
Treatments Being Tested
The overall aim of the trial is to evaluate the safety, tolerability, and p...
Status
Recruiting
Location
City of Hope National Medical Center
Start Date
2020-03-04
Trial ID
NCT04221542
Treatments Being Tested
The primary objective is to assess the activity and efficacy of pembrolizum...
Status
Active Not Recruiting
Location
San Francisco VA Medical Center, San Francisco, CA
Start Date
2020-02-20
Trial ID
NCT04104893
Treatments Being Tested
This study is being done to see how safe and effective abemaciclib is when ...
Status
Active Not Recruiting
Location
St. Joseph's Hospital and Medical Center
Start Date
2018-11-26
Trial ID
NCT03706365
Treatments Being Tested
The purpose of this study is to investigate the safety and efficacy of abir...
Status
Completed
Location
Multiple Locations
Start Date
2012-06
Trial ID
NCT01795703
Treatments Being Tested
The purpose of this study is to determine the effect of abiraterone acetate...
Status
Completed
Location
Roswell Park Cancer Institute
Start Date
2009-05
Trial ID
NCT00910754
Treatments Being Tested
To assess the safety of treating men with oligometastatic prostate cancer w...
Status
Completed
Location
Johns Hopkins Sibley Memorial Hospital
Start Date
2017-02-22
Trial ID
NCT03043807
Treatments Being Tested
This randomized phase II trial studies how well androgen receptor antagonis...
Status
Active Not Recruiting
Location
Yale Cancer Center
Start Date
2017-06-20
Trial ID
NCT02949284
The purpose of this study is to demonstrate the safety and effectiveness of...
Status
Completed
Location
Multiple Locations
Start Date
2012-03-27
Trial ID
NCT01591122
Treatments Being Tested